Lifeboat Foundation

Perovskites, which have shown enormous potential as a new semiconductor for solar cells, are gaining attention as well as a potential next-generation technology to also power spacefaring missions. As scientists around the globe continue efforts toward harnessing the potential of perovskites on Earth, others are looking into how well the technology might work in the planet’s orbit.

A collaborative research effort to collectively address this important issue involving scientists from the National Renewable Laboratory (NREL) lays out guidelines to test the radiation-tolerating properties of perovskites intended for use in space.

“Radiation is not really a concern on Earth, but becomes increasingly intense as we move to higher and higher altitudes,” said Ahmad Kirmani, a postdoctoral researcher at NREL and lead author of the new paper, “Countdown to perovskite space launch: Guidelines to performing relevant radiation-hardness experiments,” which appears in Joule.

A long-standing mystery about early cells has a solution—and it’s a rather magical one.

Combating Antibiotic-Resistant Bacteria — Dr. Erin Duffy, Ph.D., Chief of Research & Development, and Kevin Outterson, ESQ., Executive Director, CARB-X.

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X — https://carb-x.org/) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world. 1.27 million deaths worldwide were attributed to resistant bacterial infections in 2019.

Continue reading “Dr. Erin Duffy, Ph.D. & Kevin Outterson, ESQ — Combating Antibiotic-Resistant Bacteria (CARB-X)” »

Targeting Root Causes Of Diseases And Aging — Dr. Andrew Adams, Ph.D., Vice President, Neurodegeneration Research; Co-Director, Lilly Institute for Genetic Medicine, Eli Lilly.

Dr. Andrew Adams, Ph.D. is Vice President of Neurodegeneration Research at Eli Lilly (https://www.lilly.com/) and Co-Director of their new Lilly Institute for Genetic Medicine (https://lilly.mediaroom.com/2022-02-22-Lilly-Announc…ort-Site), a $700 million initiative to establish an institute for researching and developing genetic medicines, specifically acting at the nucleic acid level, to advance an entirely new drug class that target the root cause of diseases, an approach that is fundamentally different than medicines available today.

Continue reading “Dr. Andrew Adams, PhD — Lilly Institute for Genetic Medicine — Targeting Root Causes Of Diseases” »

A lucky discovery involving lithium-sulfur batteries has a legitimate chance to revolutionize how we power our world.

The four Ax-1 astronauts will get to spend about 12 extra hours on the orbiting lab.

The first-ever fully private crewed mission to the International Space Station will get to spend 12 extra hours aboard the orbiting lab.

The four astronauts of Ax-1, a mission organized by Houston company Axiom Space, had been scheduled to depart the station in their SpaceX Dragon capsule at 10:35 a.m. EDT (1435 GMT) on Tuesday (April 19) and splash down off the coast of Florida early Wednesday morning (April 20).

SpaceXs brand-new Dragon spacecraft – named “Freedom” by the Crew-4 astronauts – arrived at Kennedy Space Center’s Launch Complex 39A on April 16, 2022, after making the journey from SpaceX’s processing facility at nearby Cape Canaveral Space Force Station in Florida. After Dragon is mated to the SpaceX Falcon 9 rocket, the launch vehicle will roll out to the pad and be raised to the vertical launch position.

Liftoff is scheduled for 5:26 a.m. EDT on Saturday, April 23. NASA’s Crew-4 mission is the fourth crew rotation flight on a SpaceX Dragon spacecraft and Falcon 9 rocket. NASA astronauts Kjell Lindgren and Bob Hines will serve as mission commander and pilot, respectively, and NASA astronaut Jessica Watkins and ESA (European Space Agency) astronaut Samantha Cristoforetti, will join as mission specialists.

If all goes according to plan, Jessica Watkins will become the first African-American woman to make a prolonged ISS stay.

Experiments on how anaesthetics alter the behaviour of tiny structures found in brain cells bolster the controversial idea that quantum effects in the brain might explain consciousness.